Colorectal Cancer
|
Most Recent Report |
Past Reports |
Rate: 79%
* 2012 Report (7/1/2011-6/30/2012 DOS) (* Avg: 68%)
|
| Rate: 77%
* 2011 Report (7/1/2010-6/30/2011 DOS) (* Avg: 64%)
|
|
|
Utilization of the PHQ-9 |
Most Recent Report |
Legend  | Clinic Average |  | State Average |
|
Diabetes
|
Most Recent Report |
Past Reports |
Rate: 33%
* 2013 Report (2012 DOS) (* Avg: 38%)
|
| Rate: 33%
* 2012 Report (2011 DOS) (* Avg: 38%)
| Rate: 35%
* 2011 Report (2010 DOS) (* Avg: 37%)
| Rate: 31%
* 2010 Report (2009 DOS) (* Avg: 25%)
|
|
|
Diabetes - Blood Pressure
|
Most Recent Report |
Past Reports |
Rate: 84%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 91%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 89%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 76%
* 2010 Report (2009 DOS) (* Avg: 58%)
|
|
|
Diabetes - LDL Control
|
Most Recent Report |
Past Reports |
Rate: 57%
* 2013 Report (2012 DOS) (* Avg: 62%)
|
| Rate: 54%
* 2012 Report (2011 DOS) (* Avg: 62%)
| Rate: 59%
* 2011 Report (2010 DOS) (* Avg: 60%)
| Rate: 58%
* 2010 Report (2009 DOS) (* Avg: 57%)
|
|
|
Diabetes - HbA1c Control
|
Most Recent Report |
Past Reports |
Rate: 70%
* 2013 Report (2012 DOS) (* Avg: 74%)
|
| Rate: 69%
* 2012 Report (2011 DOS) (* Avg: 75%)
| Rate: 80%
* 2011 Report (2010 DOS) (* Avg: 75%)
| Rate: 69%
* 2010 Report (2009 DOS) (* Avg: 72%)
|
|
|
Diabetes - Tobacco-free
|
Most Recent Report |
Past Reports |
Rate: 84%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 77%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 82%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 90%
* 2010 Report (2009 DOS) (* Avg: 83%)
|
|
|
Diabetes - Daily Aspirin Use
|
Most Recent Report |
Past Reports |
Rate: 100%
* 2013 Report (2012 DOS) (* Avg: 99%)
|
| Rate: 100%
* 2012 Report (2011 DOS) (* Avg: 99%)
| Rate: 100%
* 2011 Report (2010 DOS) (* Avg: 99%)
| Rate: 65%
* 2010 Report (2009 DOS) (* Avg: 86%)
|
|
|
Health Information Technology |
|
Vascular Disease
|
Most Recent Report |
Past Reports |
Rate: 58%
* 2013 Report (2012 DOS) (* Avg: 49%)
|
| Rate: 57%
* 2012 Report (2011 DOS) (* Avg: 49%)
| Rate: 57%
* 2011 Report (2010 DOS) (* Avg: 40%)
| Rate: 39%
* 2010 Report (2009 DOS) (* Avg: 34%)
|
|
|
Vascular Disease - Blood Pressure
|
Most Recent Report |
Past Reports |
Rate: 89%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 93%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 81%
* 2011 Report (2010 DOS) (* Avg: 67%)
| Rate: 61%
* 2010 Report (2009 DOS) (* Avg: 58%)
|
|
|
Vascular Disease - LDL Control
|
Most Recent Report |
Past Reports |
Rate: 68%
* 2013 Report (2012 DOS) (* Avg: 67%)
|
| Rate: 66%
* 2012 Report (2011 DOS) (* Avg: 67%)
| Rate: 65%
* 2011 Report (2010 DOS) (* Avg: 65%)
| Rate: 72%
* 2010 Report (2009 DOS) (* Avg: 64%)
|
|
|
Vascular Disease - Tobacco-free
|
Most Recent Report |
Past Reports |
Rate: 92%
* 2013 Report (2012 DOS) (* Avg: 83%)
|
| Rate: 86%
* 2012 Report (2011 DOS) (* Avg: 83%)
| Rate: 95%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 89%
* 2010 Report (2009 DOS) (* Avg: 81%)
|
|
|
Vascular Disease - Daily Aspirin Use
|
Most Recent Report |
Past Reports |
Rate: 100%
* 2013 Report (2012 DOS) (* Avg: 96%)
|
| Rate: 98%
* 2012 Report (2011 DOS) (* Avg: 95%)
| Rate: 100%
* 2011 Report (2010 DOS) (* Avg: 94%)
| Rate: 100%
* 2010 Report (2009 DOS) (* Avg: 92%)
|
|
|